Drug News

Exploring New Horizons: BCC Research Forecasts $5.2 Billion Global Induced Pluripotent Stem Cells Market by 2028

The global market for induced pluripotent stem cells (iPSCs) is poised for significant growth, according to the latest research study conducted by BCC Research. The report, titled “Pluripotent Stem Cells: Global Markets,” delves into the worldwide market for iPSCs, offering insights into their usage, geographical distribution, key players, and market worth.

The demand for iPSCs is expected to surge from $3.4 billion in 2023 to an estimated $5.2 billion by the end of 2028, representing a compound annual growth rate (CAGR) of 9.1% during the forecast period. This growth trajectory is underpinned by several key market drivers.

One of the primary drivers is the growing emphasis on research and development in the field of iPSCs. This includes endeavors to enhance understanding of iPSCs, explore their potential applications, and develop novel techniques and technologies related to iPSCs.

Moreover, increased investment in the biotechnology industry is fueling the expansion of the iPSC market. This encompasses greater funding for research, development, and commercialization of biotech products and technologies, creating a conducive environment for the proliferation of iPSC-based products and services.

Additionally, the rising prevalence of chronic diseases is driving demand for iPSCs, as these cells play a crucial role in disease modeling, drug discovery, and personalized medicine. iPSC-derived cells are utilized in testing medications for safety and efficacy, studying disease mechanisms, and developing innovative therapeutic approaches.

The report provides a comprehensive analysis of the iPSC market, covering various aspects such as reprogramming methods, applications, derived tissue cell types, product functions, end uses, and geographic regions. It segments the market based on diverse parameters, offering insights into key trends, growth prospects, and market dynamics.

Notably, iPSCs find applications in diverse fields such as drug development, academic research, and regenerative medicine. They serve functions ranging from cell differentiation and culture to cellular reprogramming and molecular engineering, facilitating a wide array of scientific investigations and therapeutic interventions.

The report forecasts significant growth in the drug development and toxicity testing segment, which is projected to dominate the market by 2028. Geographically, the United States is expected to retain the highest market share, owing to its robust biotechnology ecosystem and supportive regulatory framework.

Key players in the iPSC market include renowned entities such as ADDGENE, ALSTEM, THERMO FISHER SCIENTIFIC INC., and MERCK KGAA, among others. These companies are at the forefront of innovation in iPSC research, driving advancements in technology and product development.

In conclusion, the global market for induced pluripotent stem cells is poised for robust growth, fueled by increasing research activities, investments in biotechnology, and the imperative to address the growing burden of chronic diseases. The comprehensive insights provided by BCC Research offer valuable perspectives for stakeholders navigating this dynamic and evolving market landscape.

For further information and to access the complete research findings, interested parties are encouraged to explore the detailed report on the Worldwide Induced Pluripotent Stem Cells Market.


Joan David-Leonhard

Joan David Leonhard is a recent Pharm.D graduate with a strong passion for the pharmaceutical industry and a particular interest in pharmaceutical media and communication. Her brief internship experience includes roles in pharmacy where she built strong patient-pharmacist relationships and a pharmaceutical media internship where she actively contributed to drug information articles, blog posts, social media engagement, and various media projects.
Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker